1 terminated, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Cicatrizing Conjunctivitis: new trials by email Literature Review of Cicatrizing Conjunctivitis trials Research Report on Cicatrizing Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid Baricitinib 2 MG [Olumiant], Methotrexate, Azathioprine - Mucous Membrane Pemphigoid, Cicatrizing Conjunctivitis | Phase 2 | Terminated | Washington University School of Medicine | 2 | 2022-02-21 | 2023-11-07 |
| Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis minor salivary gland transplantation - Cicatrizing Conjunctivitis, Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | Not applicable | Unknown | National Taiwan University Hospital | 30 | 2016-09-01 | 2019-02-15 |
Pemphigoid, Benign Mucous Membrane (2) · Bronchiolitis Obliterans Syndrome (1) · Sjogren's Syndrome (1) · Stevens-Johnson Syndrome (1)
Conjunctival Diseases (2) · Eye Diseases (2) · Skin Diseases (2) · Skin Diseases, Vesiculobullous (2) · Skin and Connective Tissue Diseases (2) · Arthritis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Chemically-Induced Disorders (1) · Connective Tissue Diseases (1) · Dermatitis (1)
Azathioprine (1) · Methotrexate (1) · Mycophenolic Acid (1) · baricitinib (1)
National Taiwan University Hospital (1) · Washington University School of Medicine (1)
Taiwan (1) · United States (1)